Всесоюзный Научно-Исследовательский Технологический Институт Антибиотиков И Ферментов Медицинского Назначения
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Всесоюзный Научно-Исследовательский Технологический Институт Антибиотиков И Ферментов Медицинского НазначенияfiledCriticalВсесоюзный Научно-Исследовательский Технологический Институт Антибиотиков И Ферментов Медицинского Назначения
Priority to SU4812867/14ApriorityCriticalpatent/SU1769428A1/en
Application grantedgrantedCritical
Publication of SU1769428A1publicationCriticalpatent/SU1769428A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
FIELD: chemical technology. SUBSTANCE: method involves addition of adenosine, riboxine and polyvinylpyrrolidone to sodium salicylate aqueous solution at heating following by cooling to 30-60 C, exposition for 0.5-2 h. Mixture is titrated with sodium hydroxide solution up to pH 5.0-8.5, filtered, sterilized and lyophilized. EFFECT: increased solubility and stability of solution. 1 tbl
SU4812867/14A1990-04-091990-04-09Method of preparing of agent for cardiovascular disease treatment
SU1769428A1
(en)
Process for the preparation of a sterile injectable physiologically acceptable solution of an X-ray contrast agent and solutions of the X-ray contrast agent and a buffer
Process for preparing novel pyrrolo-benzimidazole derivatives, pyrrolo -benzoxazole derivatives and pyrrolo-benzthiazole derivatives and pharmaceutical compositions comprising the same